182 related articles for article (PubMed ID: 24460109)
1. Atypical fracture of the femur in a patient using denosumab--a case report.
Schilcher J; Aspenberg P
Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109
[No Abstract] [Full Text] [Related]
2. Atypical femoral fractures bilaterally in a patient receiving denosumab.
Drampalos E; Skarpas G; Barbounakis N; Michos I
Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
[No Abstract] [Full Text] [Related]
3. Denosumab and atypical femoral fractures.
Aspenberg P
Acta Orthop; 2014 Feb; 85(1):1. PubMed ID: 24171676
[No Abstract] [Full Text] [Related]
4. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
Ramchand SK; Chiang CY; Zebaze RM; Seeman E
Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
[TBL] [Abstract][Full Text] [Related]
6. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
[No Abstract] [Full Text] [Related]
7. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
Piponov HI; Goldstein JM; Eisenberg GM
Osteoporos Int; 2020 Nov; 31(11):2263-2267. PubMed ID: 32561954
[TBL] [Abstract][Full Text] [Related]
8. Denosumab and atypical femur fractures.
Cating-Cabral MT; Clarke BL
Maturitas; 2013 Sep; 76(1):1-2. PubMed ID: 23835004
[No Abstract] [Full Text] [Related]
9. Bilateral atypical femoral fractures in a patient prescribed denosumab - a case report.
Thompson RN; Armstrong CL; Heyburn G
Bone; 2014 Apr; 61():44-7. PubMed ID: 24389366
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
Puah KL; Tan MH
Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
[No Abstract] [Full Text] [Related]
11. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
[TBL] [Abstract][Full Text] [Related]
12. More on atypical fractures of the femoral diaphysis.
Kwek EB; Koh JS; Howe TS
N Engl J Med; 2008 Jul; 359(3):316-7; author reply 317-8. PubMed ID: 18635442
[No Abstract] [Full Text] [Related]
13. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
Einhorn TA; Bogdan Y; Tornetta P
J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
[No Abstract] [Full Text] [Related]
15. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate.
Brown JP; Roux C; Ho PR; Bolognese MA; Hall J; Bone HG; Bonnick S; van den Bergh JP; Ferreira I; Dakin P; Wagman RB; Recknor C
Osteoporos Int; 2014 Jul; 25(7):1953-61. PubMed ID: 24676847
[TBL] [Abstract][Full Text] [Related]
16. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
Cross MB; Nam D; van der Meulen MC; Bostrom MP
J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
[TBL] [Abstract][Full Text] [Related]
17. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
Josse R; Khan A; Ngui D; Shapiro M
Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
[TBL] [Abstract][Full Text] [Related]
18. Commentary: drug-associated atypical femoral fractures (DaAFFs): balancing the facts.
Pazianas M; Smith R
J Clin Endocrinol Metab; 2014 Jul; 99(7):2340-2. PubMed ID: 24712575
[No Abstract] [Full Text] [Related]
19. Denosumab is an option for treatment of osteoporosis.
Simonelli C
Am Fam Physician; 2012 Dec; 86(11):992; author reply 994. PubMed ID: 23198660
[No Abstract] [Full Text] [Related]
20. Atypical Femoral Fractures: A Teaching Perspective.
Khan AA; Leslie WD; Lentle B; Iles S; Kaiser SM; Frame H; Burrell S; Cheung AM
Can Assoc Radiol J; 2015 May; 66(2):102-7. PubMed ID: 25051904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
